The 12th Annual BIO Investor Forum

BIO Investor Forum 
Join Us October 8-9, 2013

The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and One-on-One partnering meetings.

BIO One-on-One Partnering provides an opportunity to arrange meetings between investors; companies; and industry BD, licensing and therapeutic franchise heads.

More about One-on-One Partnering events

See the 2012 Program Schedule here.

 

 

 

Industry News

  • Seattle biotech Kineta has a plan for faster investor returns: Article
  • AtheroNova Receives Russia’s Approval for Phase I Clinical Trials: Article
  • Cambridge innovation helps validate $20m investment: Article
  • Trevena lands $430M Forest deal, $60M venture round as heart drug heads to PhIIb: Article
  • Biotech Receptos claims $73M IPO prize to fuel oral MS contender: Article
     

Last year’s conference scheduled over 650 meetings. Nearly 80% of all requests were between biotech companies and investors. Furthermore, the event hosted nearly 110 late-stage private and emerging public company presentations.
 

Meetings Scheduled    

Type of Companies


BIOtechNOW Industry Analysis Blog

•  State of the Biotech Industry: Burrill’s Biotech 2013 Report: Blog
•  Venture Capital Trends: Blog
•  Finding Biotech in the Silicon Prairie: Blog